CG Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CG Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2023 to Q4 2024.
  • CG Oncology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 62.5M shares, a 1343% increase year-over-year.
  • CG Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 62.5M shares, a 1343% increase from 2023.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 62.5M +58.2M +1343% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 67.1M +62.8M +1432% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 66.6M +62.7M +1601% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 47.1M +43.2M +1121% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.33M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 4.38M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 3.92M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 3.86M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.